These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37986547)

  • 1. Evaluation of a COVID-19 fundamental nursing care guideline versus usual care: The COVID-NURSE cluster randomized controlled trial.
    Richards DA; Bollen J; Jones B; Melendez-Torres GJ; Hulme C; Cockcroft E; Cook H; Cooper J; Creanor S; Cruickshank S; Dawe P; Doris F; Iles-Smith H; Kent M; Logan P; O'Connell A; Onysk J; Owens R; Quinn L; Rafferty AM; Romanczuk L; Russell AM; Shepherd M; Singh SJ; Sugg HVR; Coon JT; Tooze S; Warren FC; Whale B; Wootton S
    J Adv Nurs; 2024 May; 80(5):2137-2152. PubMed ID: 37986547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-NURSE: evaluation of a fundamental nursing care protocol compared with care as usual on experience of care for noninvasively ventilated patients in hospital with the SARS-CoV-2 virus-protocol for a cluster randomised controlled trial.
    Richards DA; Sugg HV; Cockcroft E; Cooper J; Cruickshank S; Doris F; Hulme C; Logan P; Iles-Smith H; Melendez-Torres GJ; Rafferty AM; Reed N; Russell AM; Shepherd M; Singh SJ; Thompson Coon J; Tooze S; Wootton S; Abbott R; Bethel A; Creanor S; Quinn L; Tripp H; Warren FC; Whear R; Bollen J; Hunt HA; Kent M; Morgan L; Morley N; Romanczuk L
    BMJ Open; 2021 May; 11(5):e046436. PubMed ID: 34039574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurses' strategies for overcoming barriers to fundamental nursing care in patients with COVID-19 caused by infection with the SARS-COV-2 virus: Results from the 'COVID-NURSE' survey.
    Sugg HVR; Richards DA; Russell AM; Burnett S; Cockcroft EJ; Thompson Coon J; Cruickshank S; Doris FE; Hunt HA; Iles-Smith H; Kent M; Logan PA; Morgan LM; Morley N; Rafferty AM; Shepherd MH; Singh SJ; Tooze SJ; Whear R
    J Adv Nurs; 2023 Mar; 79(3):1003-1017. PubMed ID: 35467757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrIn RCT.
    das Nair R; Bradshaw LE; Carpenter H; Clarke S; Day F; Drummond A; Fitzsimmons D; Harris S; Montgomery AA; Newby G; Sackley C; Lincoln NB
    Health Technol Assess; 2019 Apr; 23(16):1-194. PubMed ID: 31032782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial.
    Bates A; Rushbrook S; Shapiro E; Grocott M; Cusack R
    Trials; 2020 Nov; 21(1):929. PubMed ID: 33203440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and outcomes of paid undergraduate student nurse positions.
    Gamroth L; Budgen C; Lougheed M
    Nurs Leadersh (Tor Ont); 2006 Sep; 19(3):e1-14. PubMed ID: 19830923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT.
    Bruce J; Mazuquin B; Mistry P; Rees S; Canaway A; Hossain A; Williamson E; Padfield EJ; Lall R; Richmond H; Chowdhury L; Lait C; Petrou S; Booth K; Lamb SE; Vidya R; Thompson AM
    Health Technol Assess; 2022 Feb; 26(15):1-124. PubMed ID: 35220995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    PRINCIPLE Trial Collaborative Group
    Lancet; 2021 Mar; 397(10279):1063-1074. PubMed ID: 33676597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Butler CC; Yu LM; Dorward J; Gbinigie O; Hayward G; Saville BR; Van Hecke O; Berry N; Detry MA; Saunders C; Fitzgerald M; Harris V; Djukanovic R; Gadola S; Kirkpatrick J; de Lusignan S; Ogburn E; Evans PH; Thomas NPB; Patel MG; Hobbs FDR;
    Lancet Respir Med; 2021 Sep; 9(9):1010-1020. PubMed ID: 34329624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT.
    Froggatt K; Best A; Bunn F; Burnside G; Coast J; Dunleavy L; Goodman C; Hardwick B; Jackson C; Kinley J; Davidson Lund A; Lynch J; Mitchell P; Myring G; Patel S; Algorta GP; Preston N; Scott D; Silvera K; Walshe C
    Health Technol Assess; 2020 Jan; 24(6):1-140. PubMed ID: 31971506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    RECOVERY Collaborative Group
    Lancet; 2022 Feb; 399(10325):665-676. PubMed ID: 35151397
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.